Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1994-10-20
1996-11-12
Davenport, Avis M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 13, 530324, 530326, A61K 3800, A61K 3802, C07K 500, C07K 700
Patent
active
055740090
ABSTRACT:
The present invention provides methods for treating mammalian diseases and conditions characterized by myelin destruction. The present invention provides methods for inducing myelin formation by myelin forming cells expressing reovirus type 3 receptors comprising administering to such cells an effective amount of a compound bindable with the reovirus type 3 receptor. The compounds for use in the method of the invention preferably comprise antibodies and peptides, more preferably synthetic peptides.
REFERENCES:
patent: 4230696 (1980-10-01), Hashim
patent: 4615884 (1986-10-01), Harshman et al.
patent: 5003044 (1991-03-01), Hunter et al.
patent: 5219837 (1993-06-01), Cohen et al.
Ventimiglia, R., et al., "Localization of .beta.-adrenaergic receptors on differentiated cells of the central nervous system in culture," Proc. Natl. Acad. Sci. USA 84:5073-5077, 1987.
Cohen Jeffrey A.
Greene Mark I.
Williams William V.
Davenport Avis M.
Trustees of the University of Pennsylvania
LandOfFree
Method of stimulating myelination of cells does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of stimulating myelination of cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of stimulating myelination of cells will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-562541